Prospects for γδ T cells and chimeric antigen receptor γδ T cells in cancer immunotherapy

γδ T cells, a type of specialized T cell, differ from alpha-beta T cells due to the presence of γ and δ chain surface T cell receptors. These receptors allow them to directly recognize and bind antigenic molecules without the requirement of attachment to MHC or APC antigen presentation. Given their...

Full description

Saved in:
Bibliographic Details
Main Authors: Lu Wang, Jiaqi Li, Yaping Xuan, Jinrui Zhang, Xiao Wang, Wei Hu, Lei Xiu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1554541/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850172014612971520
author Lu Wang
Jiaqi Li
Yaping Xuan
Jinrui Zhang
Xiao Wang
Wei Hu
Wei Hu
Wei Hu
Lei Xiu
author_facet Lu Wang
Jiaqi Li
Yaping Xuan
Jinrui Zhang
Xiao Wang
Wei Hu
Wei Hu
Wei Hu
Lei Xiu
author_sort Lu Wang
collection DOAJ
description γδ T cells, a type of specialized T cell, differ from alpha-beta T cells due to the presence of γ and δ chain surface T cell receptors. These receptors allow them to directly recognize and bind antigenic molecules without the requirement of attachment to MHC or APC antigen presentation. Given their intrinsic properties and functional versatility, γδ T cells are under intensive investigation as carriers for chimeric antigen receptor (CAR) in the context of cancer therapy. In this regard, γδ CAR-T cells have demonstrated great potential to overcome the limitations of antigen recognition with the help of dual antigen identification mechanisms. However, there are still technological challenges that need to be addressed. This discussion focuses on the research status and future development prospects of γδ T cells and γδ CAR-T cells, aiming to provide valuable insights for the follow-up research and practical application of γδ CAR-T cells.
format Article
id doaj-art-efc92c1203f74d9aac17a057a3db044e
institution OA Journals
issn 1664-3224
language English
publishDate 2025-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-efc92c1203f74d9aac17a057a3db044e2025-08-20T02:20:10ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-04-011610.3389/fimmu.2025.15545411554541Prospects for γδ T cells and chimeric antigen receptor γδ T cells in cancer immunotherapyLu Wang0Jiaqi Li1Yaping Xuan2Jinrui Zhang3Xiao Wang4Wei Hu5Wei Hu6Wei Hu7Lei Xiu8State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock, Institutes of Biomedical Sciences, School of Life Sciences, Inner Mongolia University, Hohhot, ChinaState Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock, Institutes of Biomedical Sciences, School of Life Sciences, Inner Mongolia University, Hohhot, ChinaState Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock, Institutes of Biomedical Sciences, School of Life Sciences, Inner Mongolia University, Hohhot, ChinaState Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock, Institutes of Biomedical Sciences, School of Life Sciences, Inner Mongolia University, Hohhot, ChinaState Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock, Institutes of Biomedical Sciences, School of Life Sciences, Inner Mongolia University, Hohhot, ChinaState Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock, Institutes of Biomedical Sciences, School of Life Sciences, Inner Mongolia University, Hohhot, ChinaState Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, ChinaDepartment of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, ChinaState Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock, Institutes of Biomedical Sciences, School of Life Sciences, Inner Mongolia University, Hohhot, Chinaγδ T cells, a type of specialized T cell, differ from alpha-beta T cells due to the presence of γ and δ chain surface T cell receptors. These receptors allow them to directly recognize and bind antigenic molecules without the requirement of attachment to MHC or APC antigen presentation. Given their intrinsic properties and functional versatility, γδ T cells are under intensive investigation as carriers for chimeric antigen receptor (CAR) in the context of cancer therapy. In this regard, γδ CAR-T cells have demonstrated great potential to overcome the limitations of antigen recognition with the help of dual antigen identification mechanisms. However, there are still technological challenges that need to be addressed. This discussion focuses on the research status and future development prospects of γδ T cells and γδ CAR-T cells, aiming to provide valuable insights for the follow-up research and practical application of γδ CAR-T cells.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1554541/fullγδ T cellsγδ CAR-T cellscancer therapyanti-tumor responsespro-tumor response
spellingShingle Lu Wang
Jiaqi Li
Yaping Xuan
Jinrui Zhang
Xiao Wang
Wei Hu
Wei Hu
Wei Hu
Lei Xiu
Prospects for γδ T cells and chimeric antigen receptor γδ T cells in cancer immunotherapy
Frontiers in Immunology
γδ T cells
γδ CAR-T cells
cancer therapy
anti-tumor responses
pro-tumor response
title Prospects for γδ T cells and chimeric antigen receptor γδ T cells in cancer immunotherapy
title_full Prospects for γδ T cells and chimeric antigen receptor γδ T cells in cancer immunotherapy
title_fullStr Prospects for γδ T cells and chimeric antigen receptor γδ T cells in cancer immunotherapy
title_full_unstemmed Prospects for γδ T cells and chimeric antigen receptor γδ T cells in cancer immunotherapy
title_short Prospects for γδ T cells and chimeric antigen receptor γδ T cells in cancer immunotherapy
title_sort prospects for γδ t cells and chimeric antigen receptor γδ t cells in cancer immunotherapy
topic γδ T cells
γδ CAR-T cells
cancer therapy
anti-tumor responses
pro-tumor response
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1554541/full
work_keys_str_mv AT luwang prospectsforgdtcellsandchimericantigenreceptorgdtcellsincancerimmunotherapy
AT jiaqili prospectsforgdtcellsandchimericantigenreceptorgdtcellsincancerimmunotherapy
AT yapingxuan prospectsforgdtcellsandchimericantigenreceptorgdtcellsincancerimmunotherapy
AT jinruizhang prospectsforgdtcellsandchimericantigenreceptorgdtcellsincancerimmunotherapy
AT xiaowang prospectsforgdtcellsandchimericantigenreceptorgdtcellsincancerimmunotherapy
AT weihu prospectsforgdtcellsandchimericantigenreceptorgdtcellsincancerimmunotherapy
AT weihu prospectsforgdtcellsandchimericantigenreceptorgdtcellsincancerimmunotherapy
AT weihu prospectsforgdtcellsandchimericantigenreceptorgdtcellsincancerimmunotherapy
AT leixiu prospectsforgdtcellsandchimericantigenreceptorgdtcellsincancerimmunotherapy